Samuel F. Gilbert

Analysis of Treatment Efficacy, Cosmesis, and Toxicity Using the MammoSite Breast Brachytherapy Catheter to Deliver Accelerated Partial-Breast Irradiation: The William Beaumont Hospital Experience

K. Chao, Frank A. Vicini, Michelle Wallace et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 135 citations

Toxicity Using, Radiation Medicine, Breast Oncology +11

<i>PIK3CA</i> and <i>AKT1</i> Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System

Julia A. Beaver, John P. Gustin, Kyung Hee Yi et al. · Clinical Cancer Research · 2013 · 102 citations · Full text

Long-Term Efficacy and Patterns of Failure After Accelerated Partial Breast Irradiation: A Molecular Assay–Based Clonality Evaluation

Frank A. Vicini, J. Vito Antonucci, Michelle Wallace et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 87 citations

Radiation Medicine, Breast Oncology, Radiation Therapy +12

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells

Mikella Robinson, Samuel F. Gilbert, Jennifer A. Waters et al. · Cancers · 2021 · 77 citations · Full text

Developmental Biology, Endocrine-related Cancer, Tumor-initiating Cells +14

MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer

Yoshimi Endo Greer, Samuel F. Gilbert, Brunilde Gril et al. · Breast Cancer Research · 2019 · 69 citations · Full text